|
HS Code |
580737 |
| Product Name | Z-L-Valine |
| Synonym | N-Carbobenzyloxy-L-valine |
| Cas Number | 1437-39-0 |
| Molecular Formula | C12H15NO4 |
| Molecular Weight | 237.25 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 81-83°C |
| Solubility | Slightly soluble in water, soluble in ethanol and DMSO |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Optical Activity | [α]20/D +25° to +28° (c=1, ethanol) |
| Application | Peptide synthesis intermediate |
As an accredited Z-L-Valine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of Z-L-Valine, sealed with a screw cap for protection against light and moisture, labeled accordingly. |
| Shipping | Z-L-Valine is shipped in tightly sealed containers to prevent contamination and moisture absorption. It is protected from light and stored at room temperature. Transportation follows all relevant chemical safety regulations, ensuring the product’s stability and integrity. Proper labeling and documentation accompany each shipment for safe handling and compliance. |
| Storage | Z-L-Valine should be stored in a cool, dry place away from direct sunlight and moisture. Keep the container tightly closed and in a well-ventilated area, preferably at 2-8°C (refrigerated). Avoid contact with incompatible substances such as strong oxidizers. Ensure proper labeling and prevent contamination. Handle following standard laboratory safety practices to maintain chemical stability and integrity. |
|
Purity 99%: Z-L-Valine with purity 99% is used in peptide synthesis for pharmaceutical manufacturing, where it ensures high yield and biological activity of target peptides. Melting Point 180°C: Z-L-Valine with a melting point of 180°C is used in solid-phase peptide synthesis protocols, where it enables thermal stability during high-temperature reactions. Molecular Weight 267.3 g/mol: Z-L-Valine with a molecular weight of 267.3 g/mol is used in custom amino acid formulations, where it allows precise control over peptide chain assembly. Optical Rotation +28°: Z-L-Valine with optical rotation +28° is used in chiral separation processes, where it guarantees enantiomeric purity for stereoselective pharmaceutical applications. Particle Size <100 µm: Z-L-Valine with particle size less than 100 µm is used in injectable peptide preparations, where it enhances solubility and homogeneity in aqueous solutions. Stability Temperature 25°C: Z-L-Valine with a stability temperature of 25°C is used in ambient storage of lab reagents, where it maintains structural integrity and consistency over time. Water Content ≤0.5%: Z-L-Valine with water content not exceeding 0.5% is used in lyophilized bioproduct preparation, where it reduces the risk of hydrolysis and degradation during storage. HPLC Assay ≥99%: Z-L-Valine with HPLC assay greater than or equal to 99% is used in pharmaceutical reference standards, where it provides reliable quantification and quality assurance. Endotoxin Level <0.1 EU/mg: Z-L-Valine with endotoxin level less than 0.1 EU/mg is used in sterile API production, where it minimizes the risk of immunogenic response in therapeutic formulations. Residual Solvents <0.01%: Z-L-Valine with residual solvents below 0.01% is used in critical research grade applications, where it ensures compliance with stringent regulatory standards for safety. |
Competitive Z-L-Valine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Z-L-Valine has carved out a unique place in research and industry, offering more than a basic amino acid derivative. People working in peptide synthesis, pharmaceutical development, or academic labs often run into roadblocks when standard building blocks don’t deliver the purity or consistency needed. Z-L-Valine delivers a level of quality that takes a lot of the guesswork out of planning and running experiments. Given the growing demand for higher standards in healthcare, drug discovery, and biotechnology, a product like Z-L-Valine doesn’t just fill a shelf; it pushes progress forward.
A lot gets promised with specialty amino acids, but not every product stands up under scrutiny. Z-L-Valine typically arrives as a white to off-white crystalline powder, and that might not sound dramatic, but anyone in chemical research knows the value of appearance as a quick check on quality. Z-L-Valine’s structural backbone, N-[(benzyloxy)carbonyl]-L-valine, anchors it as a protected valine derivative, which carries weight for those building intricate peptide chains or protecting specific functional groups in synthesis. Its molecular formula, C12H15NO4, and a well-defined molecular weight of about 237.25 g/mol make it easy to calculate and use in planning reactions. The melting point tends to fall in the expected range, giving a dependable signpost of identity. For those concerned about moisture, it’s reassuring that Z-L-Valine is often shipped and stored under dry conditions, a detail I appreciate since water exposure can throw off an entire batch.
In hands-on research, Z-L-Valine shows its true value as more than just a component. Researchers reaching for it rarely do so only for simple chemistry; its use stretches into solid-phase peptide synthesis, providing a crack-resistant backbone for multi-step procedures. Anyone who’s spent hours troubleshooting incomplete couplings or side reactions understands why a reliable building block matters. In my experience, having consistent Z-protection on the alpha-amino group frees up the chemistry on the carboxyl and side chain, which leads to fewer unwanted side products. That translates into higher yields and cleaner reaction profiles. Drug manufacturers find Z-L-Valine an ideal choice when working with enzymes or other labile reagents, since its stability cuts back on degradation. Even in advanced biology classrooms, it often turns up as a teaching reagent to help new scientists iron out the kinks of peptide design.
The chemical marketplace is loaded with amino acid derivatives, yet most fail to hit the right mix of purity and practicality. Z-L-Valine keeps its edge with consistently high optical purity, critical when running reactions where enantiomeric excess has downstream effects. The use of the benzyloxycarbonyl protecting group isn’t just tradition—it answers modern laboratory demands for robust, non-interfering protection that still comes off cleanly when it’s time for deprotection. This isn’t always the case with tert-butoxycarbonyl or fluorenylmethyloxycarbonyl protected versions, where fouling or incomplete cleavage can add hours of busywork to clean up. Anyone who’s ever had to re-purify a peptide knows the frustration of second-guessing their starting materials.
Supplying high-grade Z-L-Valine means getting past the usual complaint of batch-to-batch variability. In my lab work, receiving a container from a trusted source often translates to less time rechecking calibrations and more time focusing on the real science. Analytical data—such as NMR, IR, and chromatogram profiles—add a practical layer of transparency. Instead of hiding behind a technical sheet, Z-L-Valine’s producers attach these profiles so people can double-check the details themselves. This small act breeds trust and speeds up project timelines. Years of seeing projects delayed by substandard reagents motivate a search for products with clearer traceability, and Z-L-Valine fits the bill.
Late-night peptide synthesis often means chasing targets that resist easy assembly or purification. Z-L-Valine pays off in situations where scale-up from milligrams to larger batches would push lesser products to their breaking point. Research groups chasing novel antibiotics, cancer inhibitors, or antiglycemic agents often need a customizable pathway through peptide synthesis. Z-L-Valine’s compatibility with respected automatized synthesizers, such as those from Biotage or CEM, helps bridge the gap between benchtop ideas and preclinical synthesis. Organizing a large peptide project, the choice of protected amino acids takes real stakes—poor solubility or unexpected contaminants can derail an entire workflow. Z-L-Valine, selected for projects on its reputation, tends to deliver sharp resolution at the final analytical stage.
A growing number of therapeutic peptides launched over the last decade build on protected amino acids. During my stint in a biotech startup, we fought through the challenge of designing a short peptide for cell-penetrating studies. Using poorly defined reagents at any step risked contract manufacture delays or, worse, regulatory setbacks. Z-L-Valine emerged as one of the few protected building blocks that maintained our process integrity across several runs, saving weeks on troubleshooting and ensuring clean submission data for regulatory filings.
Working in regulated spaces like pharmaceuticals and food additives demands more than good intentions. Z-L-Valine’s track record in documentation brings it into compliance with strict local and global standards, which means fewer last-minute certificate requests or cross-checks before audits. Analytical labs appreciate when suppliers go beyond minimum disclosure, providing both batch-specific certificates of analysis and in-depth QC results. It’s the kind of data-driven approach that makes a difference to teams juggling deadlines and worried about the reproducibility that regulators hone in on.
There’s ongoing demand for reproducibility in the published scientific literature, and Z-L-Valine helps close the gap between academic publications and industrial processes. Much of this comes down to traceability, where every step from raw input to finished reagent tracks back to a validated source and characterized process. Anyone who’s had to pacify a regulatory agency or journal reviewer asking about inconsistent data knows that running reactions with Z-L-Valine gives a level of confidence standard products can’t always match. Scientists pushing for publication in leading medical journals, or working with contract manufacturers, regularly highlight this advantage.
Safe handling and responsible sourcing stand out as priorities at every level of the supply chain. Z-L-Valine, thanks to its physical stability and ease of storage away from moisture and light, lines up well with common laboratory safety practices. Unlike more volatile or reactive amino acids, Z-L-Valine does not present acute hazards in typical chemical practice settings, assuming standard laboratory personal protective equipment and ventilation.
Environmental pressures are only going to increase, especially in peptide chemistry where traces can build up in the waste stream. Z-L-Valine supports easier cleanup with minimal hazardous by-products under controlled reaction conditions. My previous collaborations with industrial-scale peptide manufacturers underlined the difference between well-behaved starting materials and those that turn up as persistent environmental contaminants. Careful choice of Z-protection through Z-L-Valine helps streamline downstream deprotection and disposal, since benzyloxycarbonyl groups can often be cleaved and separated without harsh solvents. This approach reduces long-term waste concerns and meets the evolving requirements of green chemistry.
The importance of continuity in supply chains for specialty chemicals becomes obvious when new drug projects or high-throughput screening efforts stall because of backorders or inconsistent materials. Z-L-Valine suppliers tend to recognize these realities, building stronger relationships with both research labs and industrial buyers. The reliance on fewer, trusted intermediaries means fewer surprises during audits, and, based on my conversations with purchasing teams and QC managers, this leads to long-term contracts instead of last-minute scrambling.
Drug development doesn’t pause for supply chain issues, yet that’s an everyday reality for many research teams. Smooth scale transitions, from early discovery through to process chemistry, need reliable building blocks. Z-L-Valine allows scientists to focus their energy where it counts. Reducing the mental and administrative burden frees up time to move past development plateaus.
During my own experience scaling up peptide projects, the risk of process drift or contamination grew with batch size. Reliable reagents like Z-L-Valine absorbed a lot of risk, especially when moving from analytical sample prep to semi-industrial runs. Anyone using millions of dollars' worth of automated synthesizers, robotics, or high-pressure chromatography knows the margin for error tightens up. It makes a difference to rely on materials with independently verified purity, detailed impurity profiles, and well-understood storage requirements.
Z-L-Valine has quietly powered advances in peptide therapeutics and complex molecule development over recent years. Researchers looking to overcome stubborn issues—like racemization or incomplete deprotection—often return to Z-L-Valine after trying more exotic or expensive alternatives. Its structure, combining a natural amino acid backbone with a well-placed Z-group, minimizes side reactions and reduces steps in purification workflows. Compared to FMOC-L-Valine or BOC-L-Valine, the Z-protected variation has remained popular because the by-products of deprotection are cleaner and easier to remove.
The bigger story is cost control. Specialty reagents can sink a project’s budget fast if they underperform, either by introducing variable yields or by adding clean-up costs. Z-L-Valine’s track record gives researchers a more predictable outcome and fits the growing need to justify purchases based on performance over time. The consistency provided by high-grade batches lets project managers plan longer term and reduce the unpredictability baked into many biotech timelines.
New classes of antidiabetic drugs, antimicrobial peptides, or protease inhibitors often build their success on dependable chemistry early in the pipeline. Z-L-Valine has supported projects where even minor yield boosts translate into major time savings at pilot scale. Industrial teams appreciate reagents that minimize the need for quality retesting and cut back on extra purification cycles. During a stint tracking the development cycles of generics, I saw teams choose Z-L-Valine because regulators flagged inconsistent impurities with other building blocks. This made the difference between a lengthy hold-up and a project that cleared review with minimal friction.
Students and new lab staff learn quickly that their reputation rides not just on following protocols, but on understanding the underlying chemistry. Z-L-Valine offers a teaching moment by showing how a thoughtful choice of protected amino acid can impact a whole chain of decisions. More educational settings are highlighting its use, not as a niche tool, but as a demonstration of smart, modern chemical engineering.
The protected amino acid landscape may feel crowded, but real differentiation comes from experience and consistent proof. Z-L-Valine earns its spot through a combination of trustworthy purity, easy-to-track analytical support, and low-risk handling. No one wants to burn hours rerunning a failed coupling or untangling an impurity mystery. Z-L-Valine’s consistency finds quiet respect across labs and industries. I’ve seen researchers stick with it across changing projects and tech upgrades, staying loyal because too many other options overpromise or let them down when stakes run high.
Technical advances in analytical chemistry and automation have only raised the bar for starting materials. Labs adopting better chromatographic techniques or faster spectroscopic analysis demand suppliers keep up. Only a select tier of chemical manufacturers consistently hits those marks. Z-L-Valine’s record shows that transparent documentation isn’t just a sales point; it’s a guarantee that new research, new drugs, and new products start on solid footing.
Though Z-L-Valine already serves the peptide community well, challenges remain. Demand for more sustainable production, improved batch tracking, and green chemistry practices continues to grow. Suppliers can build on proven processes by offering open data on trace contaminants and by refining their synthesis to limit by-products. Digital integration of batch certificates speeds up regulatory approval and makes traceability a true end-to-end reality. In my experience, supply chain transparency often makes or breaks project timelines—and trust.
Educational programs can do more to connect students with the reality of choosing reagents like Z-L-Valine, blending theory with hands-on skill-building. Modern labs working with automation or high-throughput platforms benefit most from building strong relationships with suppliers committed to ongoing innovation. Chemical safety, waste reduction, and reduced environmental impact can be addressed in parallel with excellent manufacturing and documentation. Z-L-Valine, already a workhorse in chemistry labs, can keep advancing with a focus on long-term partnerships rather than quick sales.
What stands out in every account of Z-L-Valine is the product’s ability to keep work moving. Innovation in research may draw headlines, but steady, trouble-free supply of high-quality reagents often dictates who gets the breakthroughs first. Z-L-Valine embodies the kind of reliability needed by chemists, researchers, and manufacturers set on reducing guesswork and climbing the next step in drug discovery or industrial chemistry. Whether building a complex peptide or training the next generation of scientists, Z-L-Valine continues to prove itself as a grounded, well-chosen resource.